 |
 Previous Article | Next Article 
The Journal of Neuroscience, March 1, 1999, 19(5):1717-1727
The Amyloid Precursor Protein Interacts with Go
Heterotrimeric Protein within a Cell Compartment Specialized in
Signal Transduction
Emmanuel
Brouillet1,
Alain
Trembleau1,
Damien
Galanaud1,
Michel
Volovitch1, 2,
Colette
Bouillot1,
Cécile
Valenza1,
Alain
Prochiantz1, and
Bernadette
Allinquant1
1 Centre National de la Recherche Scientifique, Unité
de Recherche Associée 1414, Ecole Normale Supérieure, 75230 Paris Cedex 05, France, and 2 Université Paris 7, Unité de Formation et de Recherche de Biologie, 75005 Paris,
France
The function of the  -amyloid protein precursor (APP), a
transmembrane molecule involved in Alzheimer pathologies, is poorly understood. We recently reported the presence of a fraction of APP
in cholesterol and sphingoglycolipid-enriched microdomains (CSEM), a
caveolae-like compartment specialized in signal transduction. To
investigate whether APP actually interferes with cell signaling, we
reexamined the interaction between APP and Go
GTPase. In strong contrast with results obtained with reconstituted
phospholipid vesicles (Okamoto et al., 1995), we find that incubating
total neuronal membranes with 22C11, an antibody that recognizes
an N-terminal APP epitope, reduces high-affinity
Go GTPase activity. This inhibition is specific of
G o and is reproduced, in the absence of 22C11, by the
addition of the APP C-terminal domain but not by two distinct
mutated APP C-terminal domains that do not bind Go.
This inhibition of Go GTPase activity by either 22C11 or
wild-type APP cytoplasmic domain suggests that intracellular
interactions between APP and Go could be regulated by
extracellular signals. To verify whether this interaction is preserved
in CSEM, we first used biochemical, immunocytochemical, and
ultrastructural techniques to unambiguously confirm the colocalization of Go and APP in CSEM. We show that inhibition of
basal Go GTPase activity also occurs within CSEM and
correlates with the coimmunoprecipitation of Go and
APP. The regulation of Go GTPase activity by APP
in a compartment specialized in signaling may have important
consequences for our understanding of the physiopathological functions
of APP.
Key words:
APP; Alzheimer's disease; microdomains; signal
transduction; G-proteins; nervous system
Copyright © 1999 Society for Neuroscience 0270-6474/99/1951717-11$05.00/0
This article has been cited by other articles:
|
|
|
|
 
D. Kaden, P. Voigt, L.-M. Munter, K. D. Bobowski, M. Schaefer, and G. Multhaup
Subcellular localization and dimerization of APLP1 are strikingly different from APP and APLP2
J. Cell Sci.,
February 1, 2009;
122(3):
368 - 377.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Laifenfeld, L. J. Patzek, D. L. McPhie, Y. Chen, Y. Levites, A. M. Cataldo, and R. L. Neve
Rab5 Mediates an Amyloid Precursor Protein Signaling Pathway That Leads to Apoptosis
J. Neurosci.,
July 4, 2007;
27(27):
7141 - 7153.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Ashley, M. Packard, B. Ataman, and V. Budnik
Fasciclin II Signals New Synapse Formation through Amyloid Precursor Protein and the Scaffolding Protein dX11/Mint
J. Neurosci.,
June 22, 2005;
25(25):
5943 - 5955.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Caille, B. Allinquant, E. Dupont, C. Bouillot, A. Langer, U. Muller, and A. Prochiantz
Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone
Development,
May 1, 2004;
131(9):
2173 - 2181.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Sondag and C. K. Combs
Amyloid Precursor Protein Mediates Proinflammatory Activation of Monocytic Lineage Cells
J. Biol. Chem.,
April 2, 2004;
279(14):
14456 - 14463.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Muresan and V. Muresan
A phosphorylated, carboxy-terminal fragment of {beta}-amyloid precursor protein localizes to the splicing factor compartment
Hum. Mol. Genet.,
March 1, 2004;
13(5):
475 - 488.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. D. Toran-Allerand
Minireview: A Plethora of Estrogen Receptors in the Brain: Where Will It End?
Endocrinology,
March 1, 2004;
145(3):
1069 - 1074.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Hashimoto, T. Niikura, T. Chiba, E. Tsukamoto, H. Kadowaki, H. Nishitoh, Y. Yamagishi, M. Ishizaka, M. Yamada, M. Nawa, et al.
The Cytoplasmic Domain of Alzheimer's Amyloid-{beta} Protein Precursor Causes Sustained Apoptosis Signal-Regulating Kinase 1/c-Jun NH2-Terminal Kinase-Mediated Neurotoxic Signal via Dimerization
J. Pharmacol. Exp. Ther.,
September 1, 2003;
306(3):
889 - 902.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. McPhie, R. Coopersmith, A. Hines-Peralta, Y. Chen, K. J. Ivins, S. P. Manly, M. R. Kozlowski, K. A. Neve, and R. L. Neve
DNA Synthesis and Neuronal Apoptosis Caused by Familial Alzheimer Disease Mutants of the Amyloid Precursor Protein Are Mediated by the p21 Activated Kinase PAK3
J. Neurosci.,
July 30, 2003;
23(17):
6914 - 6927.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Holtje, S. Winter, D. Walther, I. Pahner, H. Hortnagl, O. P. Ottersen, M. Bader, and G. Ahnert-Hilger
The Vesicular Monoamine Content Regulates VMAT2 Activity through Galpha q in Mouse Platelets. EVIDENCE FOR AUTOREGULATION OF VESICULAR TRANSMITTER UPTAKE
J. Biol. Chem.,
April 25, 2003;
278(18):
15850 - 15858.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Mbebi, V. See, L. Mercken, L. Pradier, U. Muller, and J.-P. Loeffler
Amyloid Precursor Protein Family-induced Neuronal Death Is Mediated by Impairment of the Neuroprotective Calcium/Calmodulin Protein Kinase IV-dependent Signaling Pathway
J. Biol. Chem.,
May 31, 2002;
277(23):
20979 - 20990.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Hashimoto, T. Niikura, Y. Ito, Y. Kita, K. Terashita, and I. Nishimoto
Neurotoxic Mechanisms by Alzheimer's Disease-Linked N141I Mutant Presenilin 2
J. Pharmacol. Exp. Ther.,
March 1, 2002;
300(3):
736 - 745.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S.-S. Wang, D. L. Rymer, and T. A. Good
Reduction in Cholesterol and Sialic Acid Content Protects Cells from the Toxic Effects of beta -Amyloid Peptides
J. Biol. Chem.,
November 2, 2001;
276(45):
42027 - 42034.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Matsuda, T. Yasukawa, Y. Homma, Y. Ito, T. Niikura, T. Hiraki, S. Hirai, S. Ohno, Y. Kita, M. Kawasumi, et al.
c-Jun N-Terminal Kinase (JNK)-Interacting Protein-1b/Islet-Brain-1 Scaffolds Alzheimer's Amyloid Precursor Protein with JNK
J. Neurosci.,
September 1, 2001;
21(17):
6597 - 6607.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Torroja, M. Packard, M. Gorczyca, K. White, and V. Budnik
The Drosophila beta -Amyloid Precursor Protein Homolog Promotes Synapse Differentiation at the Neuromuscular Junction
J. Neurosci.,
September 15, 1999;
19(18):
7793 - 7803.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Hashimoto, T. Niikura, Y. Ito, and I. Nishimoto
Multiple Mechanisms Underlie Neurotoxicity by Different Types of Alzheimer's Disease Mutations of Amyloid Precursor Protein
J. Biol. Chem.,
October 27, 2000;
275(44):
34541 - 34551.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Rymer and T. A. Good
The Role of G Protein Activation in the Toxicity of Amyloidogenic Abeta -(1-40), Abeta -(25-35), and Bovine Calcitonin
J. Biol. Chem.,
January 19, 2001;
276(4):
2523 - 2530.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Kajkowski, C. F. Lo, X. Ning, S. Walker, H. J. Sofia, W. Wang, W. Edris, P. Chanda, E. Wagner, S. Vile, et al.
beta -Amyloid Peptide-induced Apoptosis Regulated by a Novel Protein Containing a G Protein Activation Module
J. Biol. Chem.,
May 25, 2001;
276(22):
18748 - 18756.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
